St John of God Hospital Murdoch
Murdoch 6150
1 studies enrolling now · 3 studies all time
What they study most
Advanced or Metastatic Non-small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck
Studies at this site
- A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer — Recruiting now
- A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
- A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling